Nanopore Technology: Detecting Diseases With Single Molecule Precision
University of California, Riverside (UCR) scientists have made a groundbreaking advancement in disease detection by developing a revolutionary nanopore-based tool. This innovation promises faster and more precise diagnosis than traditional methods, capable of detecting diseases using just a single molecule.
Tiny Openings, Big Impact
The breakthrough relies on nanopores—tiny openings one-billionth of a meter wide. These pores are utilized to pass individual molecules of DNA or proteins through, creating minute electrical signals. Currently, conventional tests rely on millions of molecules, often missing early signs of disease.
“Right now, you need millions of molecules to detect diseases. We’re showing that it’s possible to get useful data from just a single molecule,” says Kevin Freedman, assistant professor of bioengineering at UCR and lead author of a paper on this tool in Nature Nanotechnology.
“This level of sensitivity could make a real difference in disease diagnostics.
“>
Filtering Noise, Boosting Accuracy
Here’s what sets this device apart. Instead of external filters that could unintentionally eliminate important data, this nanopore acts as its own filter, distinguishing and analyzing subtle differences between healthy and disease-causing molecules.
By effectively eliminating background noise, it ensures precise identification, allowing doctors to distinguish even the tiniest variations critical to diagnosis and personalized treatment plans.
Fast-Acting Diagnosis: Changing Healthcare
Freedman envisions portable diagnostic devices the size of a USB drive, capable of detecting infections as early as 24 to 48 hours. Such rapid detection offers a major advantage in controlling outbreaks and enables swift treatment. “Nanopores offer a way to catch infections sooner—before symptoms appear and before the disease spreads. This kind of tool could make early diagnosis much more practical for both viral infections and chronic conditions.”
—Kevin Freedman, Assistant Professor of Bioengineering at UCR.
Beyond Diagnostics: The Future of Protein Research
Beyond diagnostic applications, the nanopore device holds significant potential for advancing protein research.
Proteins play critical roles in cell functions, even slight variations can impact our health. Differentiating healthy and disease-causing proteins is crucial but often challenging.
“There’s a lot of momentum toward developing protein sequencing because it will give us insights we can’t get from DNA alone,” Freedman says. “Nanopores allow us to study proteins in ways that weren’t possible before.”
Unlocking Protein Sequencing
Nanopores could ultimately pave the way for single molecule protein sequencing – a long-sought-after goal. Protein sequencing allows scientists to analyze how genetic instructions are expressed and modified in real-time.
This deeper understanding could revolutionize disease detection, allowing for earlier intervention and personalized treatment plans tailored to individual patients’ unique needs.
The Promise of Personalized Medicine
“There’s a lot to learn about the molecules driving health and disease,” Freedman concludes. “This tool moves us one step closer to personalized medicine.
“I’m confident that nanopores will become part of everyday life. This discovery could change how we use them moving forward.”
The combination of miniaturization and increasing affordability holds immense potential to bring nanopore technology into research labs and healthcare settings, revolutionizing diagnosis and research for a healthier future.